Overview
Gang Huang practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Menopause, Colorectal Cancer, Hemangioendothelioma, and Obesity.
They are actively involved in clinical research, co-authoring 98 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gang W. Huang
Is Gang W. Huang a top-rated expert for Menopause?
MediFind is an objective health platform that identifies experts based on real-world data. Gang W. Huang is classified as an Experienced expert for Menopause, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gang W. Huang participate in research or clinical trials?
Yes. Gang W. Huang has published 98 articles and abstracts on conditions like Menopause. You can view a list of Gang W. Huang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerHuang isExperienced. Learn about Colorectal Cancer.
- HemangioendotheliomaHuang isExperienced. Learn about Hemangioendothelioma.
- MenopauseHuang isExperienced. Learn about Menopause.
- ObesityHuang isExperienced. Learn about Obesity.
- Triple-Negative Breast CancerHuang isExperienced. Learn about Triple-Negative Breast Cancer.